Merkel cell carcinoma: A review of current advances

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 7, Issue 3, 2009, Pages 333-339

  Zhan, Frank Qian ^a   Packianathan, Vathani Sharon ^b   Zeitouni, Nathalie Charlotte ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Immunohistochemical analysis; Merkel cell carcinoma; Polyomavirus; Radiotherapy; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 20; NEUROFILAMENT PROTEIN; PROTEIN BCL 2; THYROID TRANSCRIPTION FACTOR 1;

ADJUVANT THERAPY; ALGORITHM; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CLINICAL FEATURE; CLINICAL PROTOCOL; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; INDIVIDUALIZATION; INTERDISCIPLINARY COMMUNICATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MERKEL CELL TUMOR; NEUTROPENIA; PATHOGENESIS; POLYOMA VIRUS; PREVALENCE; PROGNOSIS; REVIEW; SEPSIS; SKIN CARCINOGENESIS; TREATMENT RESPONSE; TUMOR CLASSIFICATION; ULTRAVIOLET RADIATION;

EID: 63449142024     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2009.0025     Document Type: Review

References (71)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107-110.
2. De Wolff-Peeters C, Marien K, Mebis J, Desmet V. A cutaneous APUDoma or Merkel cell tumor? A morphologically recognizable tumor with a biological and histological malignant aspect in contrast with its clinical behavior. Cancer 1980;46:1810-1816.
3. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005;89:1-4.
4. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 2007;127:2100-2103.
5. Ries LG Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Available at: http://seer.cancer.gov/faststats/index.php. Accessed January 23, 2009.
6. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58:375-381.
7. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003;49:832-841.
8. Allen PJ, Bowne WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:2300-2309.
9. Medina-Franco H, Urist MM, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001;8:204-208.
10. Chen KT. Merkel's cell (neuroendocrine) carcinoma of the vulva. Cancer 1994;73:2186-2191.
11. Yom SS, Rosenthal DI, El-Naggar AK, et al. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:761-768.
12. Eng TY, Boersma MG, Fuller CD, et al. Treatment of Merkel cell carcinoma. Am J Clin Oncol 2004;27:510-515.
13. Voog E, Biron P, Martin JP, Blay JY. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;85:2589-2595.
14. Veness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg 2005;75:275-281.
15. Richetta AG, Mancini M, Torroni A, et al. Total spontaneous regression of advanced merkel cell carcinoma after biopsy: review and a new case. Dermatol Surg 2008;34:815-822.
16. Kubo H, Matsushita S, Fukushige T, et al. Spontaneous regression of recurrent and metastatic Merkel cell carcinoma. J Dermatol 2007;34:773-777.
17. Torroni A, Lore B, Iannetti G. The importance of the head and neck region in regression of advanced MCC: a clinical report. J Craniofac Surg 2007;18:1173-1176.
18. Missotten GS, de Wolff-Rouendaal D, de Keizer RJ. Merkel cell carcinoma of the eyelid review of the literature and report of patients with Merkel cell carcinoma showing spontaneous regression. Ophthalmology 2008;115:195-1201.
19. Vesely MJ, Murray DJ, Neligan PC, et al. Complete spontaneous regression in Merkel cell carcinoma. J Plast Reconstr Aesthet Surg 2008;61:165-171.
20. Kayashima K, Ono T, Johno M, et al. Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of the skin. Arch Dermatol 1991;127:550-553.
21. Sais G, Admella C, Soler T. Spontaneous regression in primary cutaneous neuroendocrine (Merkel cell) carcinoma: a rare immune phenomenon? J Eur Acad Dermatol Vencreol 2002;16:82-83.
22. Takenaka H, Kishimoto S, Shibagaki R, et al. Merkel cell carcinoma with partial spontaneous regression: an immunohistochemical, ultrastructural, and TUNEL labeling study. Am J Dermatopathol 1997;19:614-618.
23. Herrmann G, Groth W, Krieg T, Mauch C. Complete remission of Merkel cell carcinoma of the scalp with local and regional metastases after topical treatment with dinitrochlorbenzol. J Am Acad Dermatol 2004;50:965-969.
24. Maruo K, Kayashima KI, Ono T. Regressing Merkel cell carcinoma-a case showing replacement of tumour cells by foamy cells. Br J Dermatol 2000;142:1184-1189.
25. Weedon D. Skin Pathology. 2nd ed. New York: Churchill Livingstone; 2002:989-991.
26. Ferringer T, Rogers HC, Metcalf JS. Merkel cell carcinoma in situ. J Cutan Pathol 2005;32:162-165.
27. Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007;110:1-12.
28. Bobos M, Hytiroglou P, Kostopoulos I, et al. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol 2006;28:99-104.
29. Hanly AJ, Elgart GW, Jorda M, et al. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates Merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol 2000;27:118-120.
30. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588-598.
31. Buell JF, Trofe J, Hanaway MJ, et al. Immunosuppression and Merkel cell cancer. Transplant Proc 2002;34:1780-1781.
32. Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcioma and HIV infection. Lancet 2002;359:497-498.
33. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999;8:153-158.
34. Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998;339:1247-1248.
35. Cerroni L, Kerl H. Primary cutaneous neuroendocrine (Merkel cell) carcinoma in association with squamous- and basal-cell carcinoma. Am J Dermatopathol 1997;19:610-613.
36. Hewitt JB, Sherif A, Kerr KM, Stankler L. Merkel cell and squamous cell carcinomas arising in erythema ab igne. Br J Dermatol 1993;128:591-592.
37. Jones CS, Tyring SK, Lee PC, Fine JD. Development of neuroendocrine (Merkel cell) carcinoma mixed with squamous cell carcinoma in erythema ab igne. Arch Dermatol 1988;124:110-113.
38. Gomez LG, DiMaio S, Silva EG, Mackay B. Associatioh between neuroendocrine (Merkel cell) carcinoma and squamous inoma of the skin. Am J Surg Pathol 1983;7:171-177.
39. Brenner B, Sulkes A, Rakowsky E, et al. Second neoplasms in patients with Merkel cell carcinoma. Cancer 2001;91:1358-1362.
40. Hattori H. Merkel cell carcinoma composed of small, intermediate and squamous cell foci showing mutually exclusive expression of neuroendocrine markers and cytokeratin 20. Br J Dermatol 2003;148:183-185.
41. Van Gele M, Kaghad M, Leonard JH, et al. Mutation analysis of P73 and TP53 in Merkel cell carcinoma. Br J Cancer 2000;82:823-826.
42. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100.
43. Kassem A, Schopflin A, Diaz C, et al. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 2008;68:5009-5013.
44. Shuda M, Feng H, Kwun HJ, et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 2008;105:16272-16277.
45. Van Gele M, Leonard JH, Van Roy N, et al. Combined karyotyping, CGH and M-FISH analysis allows detailed chacterization of unidentified chromosomal rearrangements in Merkel cell carcinoma. Int J Cancer 2002;101:137-145.
46. Leonard JH, Cook AL, Nancarrow D, et al. Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma. Cancer Detect Prev 2000;24:620-627.
47. Swick BL, Ravdel L, Fitzpatrick JE, Robinson W Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate. J Cutan Pathol 2008;35:197-202.
48. Kennedy MM, Blessing K, King G, Kerr KM. Expression of bcl-2 and p53 in Merkel cell carcinoma. An immunohistochemical study. Am J Dermatopathol 1996;18:273-277.
49. Plettenberg A, Pammer J, Tschachler E. Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene. Exp Dermatol 1996;5:183-188.
50. Schlagbauer-Wadl H, Klosner G, Heere-Ress E, et al. Bcl-2 antisense oligonucleotides (G3139) inhibit Merkel cell carcinoma growth in SCID mice. J Invest Dermatol 2000;114-725-730.
51. Yiengpruksawan A, Coit DG, Thaler HT, et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514-1519.
52. Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999;229:97-105.
53. Clark JR, Veness MJ, Gilbert R, et al. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck 2007;29:249-257.
54. Housman DM. Staging, Prognosis, and Treatment of Merkel Cell Carcinoma: A Population-Based Study. Department of Therapeutic Radiology. New Haven: Yale University; 2006:77.
55. Nghiem P. Merkel cell carcinoma: diagnosis management and controversies. Presented at the 66th Annual Meeting of the American Academy of Dermatology; February 1-8, 2008; San Antonio, Texas.
56. Goldberg SR, Neifeld JP, Frable WJ. Prognostic value of tumor thickness in patients with Merkel cell carcinoma. J Surg Oncol 2007;95:618-622.
57. Sandel HD IV, Day T, Richardson MS, et al. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival? Laryngoscope 2006;116:791-795.
58. Llombart B, Monteagudo C, Lopez-Guerrero JA, et al. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers. Histopathology 2005;46:622-634.
59. Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113:2549-2558.
60. Gupta SG, Wang LC, Penas PF, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685-690.
61. O'Connor WJ, Brodland DG. Merkel cell carcinoma. Dermatol Surg 1996;22:262-267.
62. Ott MJ, Tanabe KK, Gadd MA, et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999;134-388-392; discussion 392-393.
63. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001;127:149-154.
64. Veness MJ, Morgan GJ, Gebski V. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck. Head Neck 2005;27:208-216.
65. O'Connor WJ, Roenigk RK, Brodland DG. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997;23:929-933.
66. Boyer JD, Zitelli JA, Brodland DG, D'Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002;47:885-892.
67. Gollard R, Weber R, Kosty MP, et al. Merkel cell carcinoma: review of 22 cases with surgical, pathologic, and therapeutic considerations. Cancer 2000;88:1842-1851.
68. Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006;142:693-700.
69. Mortier L, Mirabel X, Fournier C, et al. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dennatol 2003;139:1587-1590.
70. Mojica P, Smith D, Ellenhom JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007;25:1043-1047.
71. Garneski KM, Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol 2007;57:166-169.